期刊文献+

慢性乙型肝炎病毒感染患者肾功能早期损伤指标变化及其影响因素 被引量:11

TThe early renal injury and its related factors in patients with chronic HBV infection
暂未订购
导出
摘要 目的了解慢性乙型肝炎病毒感染患者部分肾功能早期损伤指标变化及其影响因素。方法对2012年4月~2013年6月于武警后勤学院附属医院和天津市第三中心医院就诊的慢性乙型肝炎病毒感染患者90名进行调查,患者分别诊断为慢性乙型肝炎、乙型肝炎肝硬化及乙型肝炎病毒相关肝癌。进行尿微量白蛋白、尿转铁蛋白、尿Ig G、血清b2微球蛋白检测评价患者早期肾脏功能。并同时检测患者肝肾功能,测算患者e GFR水平,并记录患者性别、年龄、血压、体质量及药物使用情况等一般信息。比较不同诊断乙型肝炎感染患者肾脏早期功能损伤的程度是否存在不同。随后按照是否存在肾功能早期损伤将患者诊断、一般情况等纳入多因素分析,找出慢性乙型肝炎病毒感染者肾功能早期损伤指标异常可能相关因素。结果所有检测慢性乙型肝炎病毒感染者的血清肌酐水平均在正常检测范围。所有患者的e GFR异常率为12.7%,但肾功能早期损伤指标异常率高达72.2%(c2=56.25,P=0.000)。患者疾病状态不同则肾功能早期损伤指标异常情况也不相同。尿转铁蛋白在慢性乙型肝炎、乙型肝炎肝硬化及肝癌患者数值分别为(1.91±1.06)mg/L、(2.66±3.01)mg/L、(6.73±8.32)mg/L,3组间比较差异有统计学意义(F=7.669,P=0.001);尿Ig G的异常率在3组分别为4/30(13.3%),15/29(51.7%),11/30(36.7%),差异有统计学意义(F=10.39,P=0.006);血清b2微球蛋白异常率分别为10/30(33.3%),18/29(62%),23/30(76.7%),差异有统计学意义(F=12.75,P=0.002)。经Logistic回归分析,慢性乙型肝炎病毒感染者肾功能早期损伤指标异常的独立危险因素为患者年龄及疾病状态。结论我们的研究初步表明,慢性乙型肝炎病毒感染者中,肾功能早期损伤异常率明显高于e GFR异常率,患者年龄和疾病状态是导致肾功能早期损伤指标异常的独立危险因素。但这种异常的具体临床意义有待进一步观察研究。 Background Clinically, hepatitis B virus (HBV) infection has been observed to be associated with nephropathy. Regular monitoring of renal function is recommended because comorbidities or antiviral treatment might further increase the renal injury. The well-established formulae using serum creatinin. for the calculation of glomerular filtration rate (eGFR) are validated only for patients with substantially impaired re- nal function but not suitable for monitoring patients with normal renal function. There are few data of early re- nal injury evaluated in patients with chronic HBV infection. Methods A multicenter, retrospective and obser- vational study was carried out in 2 hospitals in Tianjin, China between April 2012 and June 2013. The study recruited 90 patients with chronic HBV infection who never received antivirai treatment. Based on the hepati- tis status, they were divided into three groups including chronic hepatitis group, liver cirrhosis group, and he- patic carcinoma group. Patients were assessed for early renal injury by urinary albumin, urinary transferrin,urinary IgG, and serum 13 2-microglobulin. Clinical information and other laboratory data including serum cre- atinine and eGFR were also collected for diagnosis. Patients' data from two laboratories were pooled together and analyzed among the three groups. Logistic regression analysis was conducted to determine the association between early renal injury and the variables including age, gender, comorbidities (diabetes and hypertension), and chronic disease stages. Results Serum creatinine level was in normal range in all patients. However, the abnormal rate of albumin, transferrin, IgG in urine, and serum 13 2-microglobulin were much higher than that of eGFR (72.2% vs. 12.7%, c2=56.25, P=0.000). The proportion of early renal injury was different in different status of chronic HBV infection. In patients with chronic hepatitis, cirrhosis and liver cancer, urinary transfer- rin levels were 1.91±1.06 rag/L, 2.66±3.01 mg/L, and 6.73±8.32 mg/L, (e2=7.671, P=0.001), respectively; ab- normal urinary IgG level was found in 4/30 (13.3%), 15/29 (51.7%) and 11/30 (36.7%) (F=10.39, P=0.006), respectively of the patients; abnormal 13 2-microglobulin level was found in 10/30 (33.3%), 18/29 (62%) and 23/30 (76.7%) (F=12.75, P=0.00), respectively of the patients. Logistic regression analyses showed that aged patients and liver disease status were the independent risk factors for early abnormal renal function in patients with chronic HBV infection. Conclusions The prevalence of early renal injury with normal eGFR is higher in patients with HBV infection. Age and disease status are the main factors affecting the early renal injury. As- sessment of early renal injury is required before antiviral treatment in these patients.
出处 《中国血液净化》 2015年第11期644-648,共5页 Chinese Journal of Blood Purification
基金 天津市应用基础及前沿技术计划重点项目(12JCZDJC25500) 武警后勤学院创新团队基金项目(WHTD201310) 西青医院院级课题基金面上项目(XQLX201407)
关键词 乙型肝炎病毒 肾小球滤过率 肾功能不全 肝硬化 Hepatitis B vires Glomerular filtration rate Renal insufficiency Hepatic cirrhosis
  • 相关文献

参考文献21

  • 1Acevedo J, Fernandez J, Prado V, et al. Relative adre- nal insufficiency in decompensated cirrhosis: Relation- ship to short-term risk of severe sepsis, hepatorenal syndrome, and death[J]. Hepatology, 2013,58(5):1757-65.
  • 2Urrunaga NH, Mindikoglu AL, Rockey DC. Renal dysfunc- tion in cirrhosis[J].. Curr Opin Gastroenterol, 2015,31 (3):215-23.
  • 3许涛,盛晓华,崔勇平,俞岗,严艳,刘莺,汪年松.CRRT在脓毒血症急性肾损伤患者救治中的临床研究[J].中国血液净化,2013,12(12):646-650. 被引量:71
  • 4De-Alencar-Franco-Costa D, Todiras M, Campos LA, et al. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy[J]. Acta Physi- ol (Oxf), 2015,213(3):740-6.
  • 5Shah RY, Allison ~lA, Lima JA, et al. Liver steatosis and the risk of albuminuria: the multi-ethnic study of atherosclerosis[J]. J Nephrol, published online aheadof print February25, 2015.
  • 6Satirapoj B, Tassanasorn S, Charoenpitakchai M, et al. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus[J].PLOS ONE, 2015, 10(4):e0124055.
  • 7李海,贾继东.2010版《慢性乙型肝炎防治指南》解读——慢性乙型肝炎治疗目标和适应证[J].临床肝胆病杂志,2011,27(8):791-793. 被引量:19
  • 8Angeli P, Sanyal A, Moiler S, et al. Current limits and future challenges in the management of renal dysfunc- tion in patients with cirrhosis: report from the Inter- national Club of Ascites[J]. Liver Int, 2013,33(1):16- 23.
  • 9Zaitsu J, Yamasaki T, Saeki I, et al. Serum transferrin as a predictor of prognosis for hepatic arterial infu- sion chemotherapy in advanced hepatoeellular carcinoma [J]. Hepatol Res, 2014,44(5):481-90.
  • 10Sakurai K, Sohda T, Ueda S, et al. Immunohistochemical demonstration of transferrin receptor 1 and 2 in human hepatocellular carcinoma tissue. Hepatogastroenterology [J], 2014,61(130):426-30.

二级参考文献20

  • 1Zhi-Hong Wan,Jian-Jun Wang,Shao-Li You,Hong-Ling Liu,Bing Zhu,Hong Zang,Chen Li,Jing Chen,Shao-Jie Xin.Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure[J].World Journal of Gastroenterology,2013,19(48):9432-9438. 被引量:23
  • 2无.慢性乙型肝炎防治指南[J].实用肝脏病杂志,2006,9(1):8-18. 被引量:824
  • 3全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:729
  • 4王清平,顾建文,黄健伟.胱抑素C对评估肝硬化患者肾小球滤过率的价值[J].临床和实验医学杂志,2006,5(12):1891-1893. 被引量:25
  • 5National Kidney Foundation. K/DOQI clinical practice guide- lines for chronic kidney disease; evaluation, classification, and stratification [ J ]. Am J Kidney Dis, 2002, 39 ( 2 Suppl 1): S1 - S266.
  • 6Randers E, Erlandsen EJ. Serum cystatin C as endogenous marker of the renal function review[J]. Clin Chem Lab Med, 1999, 37(4) = 389 -395.
  • 7Oppert M,Engel C,Brunkhorst FM,et al.Acute renal failure in patients with severe sepsis and septic shock-a significant independent risk factor for motality; result from the German prevalence study[J].Nephrol Dial Transplant,2008;23:904-909.
  • 8Rangel-Frausto MS,Pittet D,Costigan M,Hwang T,Davis CS,Wenzel RP.The natural history of the systemic inflammatory response syndrome(SRIS)[J].A prospective study.JAMA 1995;273:117-123.
  • 9Ronco C,Levin A,Warnock DG,et al.Improving out-comes from acute kidney injury (AKI):Report on an initiative[J].J Artif Organs,2007,30:373-376.
  • 10Schrier RW,Wang W.Acute Renal Failure and Sepsis[J].N Engl J Med,2004,351:159-169.

共引文献106

同被引文献85

  • 1WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva Switzerland: World Health Organization, May 12, 2015.
  • 2Chen YC, Su YC, Li CY, Hung SK. 13-year nationwide cohort study of chronic kidney disease risk among treatment-naYve patients with chronic hepatitis B in Taiwan. BMC Nephrol 2015; 16:110.
  • 3Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 2009; 5:677-689.
  • 4Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379:815-822.
  • 5Lee M, Oh S, Lee HJ, Yeum TS, Lee JH, Yu SJ, Kim HY, Yoon JH, Lee HS, Kim YJ. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir- based combination therapy. ] Viral Hepat 2014; 21: 873-881.
  • 6Martin P, Lau DT, Nguyen MH, Janssen HL, Dieterich DT, Peters MG, Jacobson IM. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clin Gastroenterol Hepato12015; 13:2071-2087.e16.
  • 7Esposito C, Plati A, Mazzullo T, Fasoli G, De Mauri A, Grosjean F, Mangione F, Castoldi F, Serpieri N, Cornacchia F, Dal Canton A. Renal function and functional reserve in healthy elderly individuals. J Nephro12007; 20:617-625.
  • 8Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, Southern DA, McLaughlin K, Mortis G, Culleton BF. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 2006; 69:2155-2161.
  • 9Huang JC, Lin HY, Lira LM, Chen SC, Chang JM, Hwang SJ, Tsai JC, Hung CC, Chen HC. Body mass index, mortality, and gender difference in advanced chronic kidney disease. PLoS One 2015; 10:e0126668.
  • 10Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, Allison TG, Batsis JA, Sert-Kuniyoshi FH, Lopez-Jimenez F. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 2008; 32:959-966.

引证文献11

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部